Showing results (21-30 of 83) with videos related to
Sort By:
Pageof 9
The American Journal of Medicine|June 2, 2019
Western Osteoporosis Alliance Clinical Practice Series: Treat-to-Target for OsteoporosisE Michael Lewiecki, David L Kendler, K Shawn Davison, et al.Menopause (New York, N.Y.)|July 13, 2016
Effect of conjugated estrogens/bazedoxifene on postmenopausal bone loss: pooled analysis of two randomized trialsJ Christopher Gallagher, Santiago Palacios, Kelly A Ryan, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 16, 2016
Denosumab Reduces Cortical Porosity of the Proximal Femoral Shaft in Postmenopausal Women With OsteoporosisRoger Zebaze, Cesar Libanati, Michael R McClung, et al.Journal of the American Academy of Dermatology|May 17, 2011
Morphea-like skin reactions in patients treated with the cathepsin K inhibitor balicatibThomas M Rünger, Silvano Adami, Claude-Laurent Benhamou, et al.The American Journal of Medicine|April 1, 2017
Western Osteoporosis Alliance Clinical Practice Series: Evaluating the Balance of Benefits and Risks of Long-Term Osteoporosis TherapiesDavid A Hanley, Michael R McClung, K Shawn Davison, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 15, 2009
Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapyDavid L Kendler, Christian Roux, Claude Laurent Benhamou, et al.The Journal of Clinical Endocrinology and Metabolism|May 25, 2019
Further Nonvertebral Fracture Reduction Beyond 3 Years for Up to 10 Years of Denosumab TreatmentSerge Ferrari, Peter W Butler, David L Kendler, et al.Bone|February 25, 2020
Favorable skeletal benefit/risk of long-term denosumab therapy: A virtual-twin analysis of fractures prevented relative to skeletal safety events observedSerge Ferrari, E Michael Lewiecki, Peter W Butler, et al.Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|May 30, 2006
Application of the 1994 WHO classification to populations other than postmenopausal Caucasian women: the 2005 ISCD Official PositionsWilliam D Leslie, Robert A Adler, Ghada El-Hajj Fuleihan, et al.Menopause (New York, N.Y.)|May 17, 2013
Influence of patient perceptions and preferences for osteoporosis medication on adherence behavior in the Denosumab Adherence Preference Satisfaction studyDavid L Kendler, David Macarios, Michael J Lillestol, et al.Pageof 9